“Rituximab in the Treatment of Refractory Myasthenia Gravis: Studying the Outcomes Using MMT Score And Need for Plasmapheresis in Baghdad Teaching Hospital”. Indian Journal of Forensic Medicine & Toxicology 14, no. 2 (April 29, 2020): 2505–2510. Accessed June 15, 2026. https://www.medicopublication.com/index.php/ijfmt/article/view/3485.